MP01-09 HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) FOR OBSTRUCTIVE BENIGN PROSTATE HYPERPLASIA - A SINGLE CENTRE EXPERIENCE OF MORE THAN 2,000 CONSECUTIVE CASES

INTRODUCTION AND OBJECTIVES:HoLEP is recommended by AUA guidelines as size independent gold standard for the treatment of obstructive benign prostate hyperplasia. As such, we aimed to report on perioperative outcomes and to identify predictors of prolonged postoperative catheterization time in our large single centre experience.METHODS:We retrospectively reviewed 2,131 men undergoing HoLEP at our institution between 2006-2015. Standard pre-, intra- and postoperative characteristics were analysed, while multivariable logistic regression models (MVA) aimed to identify predictors of prolonged catheterization (defined as being above groups median).RESULTS:Median age and prostate volume were 71 years (Interquartile range (IQR):66-76) and 77 ml (IQR:56-102), respectively. 465 (21.82%) patients received concomitant low-dose Aspirin, therapeutic low-weight molecular Heparin was present in 123 (5.77%), direct oral anticoagulant (DOAC) use was present in 35 (1.64%) of men. Median time of enucleation and morcellatio...